Literature DB >> 33795437

Side effect worry grows for AstraZeneca vaccine.

Gretchen Vogel, Kai Kupferschmidt.   

Abstract

Year:  2021        PMID： 33795437     DOI： 10.1126/science.372.6537.14

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.

Authors:  Lei Li; Yoshikazu Honda-Okubo; Jeremy Baldwin; Richard Bowen; Helle Bielefeldt-Ohmann; Nikolai Petrovsky
Journal:  Vaccine       Date:  2022-04-18       Impact factor: 4.169

2.  Effective Communication at Different Phases of COVID-19 Prevention: Roles, Enablers and Barriers.

Authors:  Khayriyyah Mohd Hanafiah; Celine Ng; Abdul Matiin Wan
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

3.  Access to and equitable distribution of COVID-19 vaccine in low-income countries.

Authors:  Krishna Prasad Acharya; Tirth Raj Ghimire; Supram Hosuru Subramanya
Journal:  NPJ Vaccines       Date:  2021-04-14       Impact factor: 7.344

4.  Identifying COVID-19 and H1N1 vaccination hesitancy or refusal among health care providers across North America, the United Kingdom, Europe, and Australia: a scoping review protocol.

Authors:  Allyson J Gallant; Audrey Steenbeek; Janet A Curran
Journal:  JBI Evid Synth       Date:  2022-01-01

Review 5.  Review on Approved and Inprogress COVID-19 Vaccines.

Authors:  Amir Farnudian-Habibi; Mobina Mirjani; Vahideh Montazer; Shima Aliebrahimi; Iman Katouzian; Saeed Abdolhosseini; Ali Rahmani; Hossein Keyvani; Seyed Nasser Ostad; Mazda Rad-Malekshahi
Journal:  Iran J Pharm Res       Date:  2022-01-24       Impact factor: 1.962

Review 6.  The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives.

Authors:  Stavroula Pegiou; Elpiniki Rentzeperi; Theocharis Koufakis; Symeon Metallidis; Kalliopi Kotsa
Journal:  Microbes Infect       Date:  2021-06-12       Impact factor: 2.700

7.  Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.

Authors:  Chandini Raina MacIntyre; Benjamin Veness; David Berger; Nada Hamad; Noor Bari
Journal:  Vaccine       Date:  2021-07-10       Impact factor: 4.169

Review 8.  A Narrative Review of COVID-19 Vaccines.

Authors:  Barbaros Eroglu; Rina Fajri Nuwarda; Iqbal Ramzan; Veysel Kayser
Journal:  Vaccines (Basel)       Date:  2021-12-31

9.  Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Authors:  Toshiaki Iba; Jerrold H Levy; Theodore E Warkentin
Journal:  Crit Care Med       Date:  2022-01-01       Impact factor: 9.296
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.